{"id":990659,"date":"2026-11-12T06:30:57","date_gmt":"2026-11-12T05:30:57","guid":{"rendered":"https:\/\/ru.law\/?p=bgh-iv-zr-214-25-rechtsschutz-impfschaden"},"modified":"2026-11-12T06:30:58","modified_gmt":"2026-11-12T05:30:58","slug":"bgh-iv-zr-214-25-rechtsschutz-impfschaden","status":"publish","type":"post","link":"https:\/\/ru.law\/en\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/","title":{"rendered":"BGH IV ZR 214\/25: Legal expenses insurance may not reject a claim for damages due to vaccination"},"content":{"rendered":"<h3 id=\"h-bgh-urteil-vom-11-november-2026-iv-zr-214-25-rechtsschutzversicherer-durfte-deckung-fur-klage-gegen-biontech-nicht-verweigern\" class=\"wp-block-heading\">Federal Court of Justice (BGH), judgment of November 11, 2026, IV ZR 214\/25: Legal expenses insurer was not allowed to refuse coverage for lawsuit against BioNTech<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The Federal Court of Justice has ruled on the rights of vaccine victims vis-\u00e0-vis their <a href=\"https:\/\/ru.law\/en\/versicherungsrecht\/rechtsanwalt-fuer-rechtsschutzversicherung\/\">legal expenses insurance<\/a> The legal position of insurers has been significantly strengthened. In June 2023, an insurer was not permitted to deny coverage for legal action against the manufacturer of the COVID-19 vaccine, Comirnaty, on the grounds that the vaccine had a positive benefit-risk ratio and the lawsuit was therefore hopeless. This was decided by the Fourth Civil Senate, responsible for insurance contract law, on November 11, 2026 (IV ZR 214\/25).<\/p>\n\n\n\n<h2 id=\"h-der-fall\" class=\"wp-block-heading\">The case<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The plaintiff was vaccinated with Comirnaty on May 11, June 15, and December 15, 2021. He claims to suffer from an autoimmune deficiency as a result of the vaccination. Following an injury in 2022, his feet swell and become severely painful whenever he stands for more than an hour or walks for more than half an hour.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">His legal expenses insurance covers the assertion of claims for damages. In June 2023, he requested coverage for the out-of-court pursuit of damages against the vaccine manufacturer. The insurer refused, stating that the action had no reasonable prospect of success.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Kleve Regional Court (6 O 117\/24) dismissed the coverage claim. The D\u00fcsseldorf Higher Regional Court (4 U 33\/25) upheld this decision: Based on the unanimous case law, there was no negative benefit-risk ratio for the vaccine, and therefore liability under Section 84 Paragraph 1 of the German Medicines Act (AMG) was precluded.<\/p>\n\n\n\n<h2 id=\"h-die-entscheidung-des-bundesgerichtshofs\" class=\"wp-block-heading\">The decision of the Federal Court of Justice<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The plaintiff's appeal was successful. The Federal Court of Justice (BGH) overturned the judgment of the Higher Regional Court of D\u00fcsseldorf and remanded the case for a new trial. The key reasons were:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Low barrier to success:<\/strong> A sufficient prospect of success exists if the policyholder's legal position appears tenable and evidence can be presented. Excessive requirements are inadmissible.<\/li>\n\n\n\n<li><strong>The decisive factor is the time of rejection:<\/strong> It basically depends on the point in time at which the insurer decides on coverage, in this case June 2023. At that time, there were still no court decisions regarding the manufacturer's liability for Comirnaty.<\/li>\n\n\n\n<li><strong>Difficult questions do not belong in the cover process:<\/strong> The assessment of the benefit-risk ratio depends on complex, unresolved legal and factual issues. The insurer may not decide these issues in advance, to the detriment of the insured, during a coverage dispute.<\/li>\n\n\n\n<li><strong>Later court rulings do not count:<\/strong> The judgments issued after the rejection at best establish a temporary prevailing opinion among the lower courts. They do not constitute a definitive ruling by the highest court to the detriment of the injured parties, especially since the Federal Court of Justice (BGH) strengthened the rights of injured parties on March 9, 2026 (VI ZR 335\/24).<\/li>\n\n\n\n<li><strong>Expert opinion instead of prejudgment:<\/strong> If a negative benefit-risk ratio is sufficiently demonstrated, the court must obtain an expert opinion. It is not apparent that the taking of evidence would most likely be unfavorable to the plaintiff.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The Higher Regional Court of D\u00fcsseldorf must now examine whether the plaintiff's submissions meet the requirements. In cases of pharmaceutical liability, the requirements for substantiation are not excessive. The details are summarized in the <a href=\"https:\/\/www.bundesgerichtshof.de\/SharedDocs\/Pressemitteilungen\/DE\/2026\/2026220.html\">Press release of the Federal Court of Justice No. 220\/2026<\/a> together.<\/p>\n\n\n\n<h2 id=\"h-was-das-urteil-fur-impfgeschadigte-bedeutet\" class=\"wp-block-heading\">What the verdict means for those injured by vaccines<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Many legal expenses insurers have rejected coverage requests for lawsuits against vaccine manufacturers, citing the approval of the vaccines and a positive benefit-risk ratio. This justification is no longer valid following the ruling. This establishes a precedent set by the highest court, which had already been emerging in the jurisprudence of the higher regional courts: Even the <a href=\"https:\/\/ru.law\/en\/olg-karlsruhe-rechtsschutz-impfschaden-urteil\/\">Higher Regional Court of Karlsruhe<\/a> and that <a href=\"https:\/\/ru.law\/en\/saarlaendisches-olg-rechtsschutz-impfschaden-urteil\/\">Saarland Higher Regional Court<\/a> have ordered legal expenses insurers to cover the costs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Together with the ruling of the Sixth Civil Senate of March 9, 2026, a clear picture emerges. Courts may not dismiss vaccine injury claims without an expert opinion, and legal expenses insurers may not refuse to finance such claims on the same grounds. As the Higher Regional Court of Cologne has ruled in several cases, <a href=\"https:\/\/ru.law\/en\/olg-koeln-5-u-84-25-impfschaden-biontech\/\">The approval of the vaccine does not replace a medical assessment.<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">New data on side effects has also emerged. <a href=\"https:\/\/ru.law\/en\/safevac-2-0-pei-studie-impfschaden\/\">SafeVac 2.0 study by the Paul Ehrlich Institute<\/a> The results, with almost 740,000 participants, have now been published and play a role in assessing the benefit-risk ratio.<\/p>\n\n\n\n<h2 id=\"h-ihre-deckung-wurde-abgelehnt-so-gehen-sie-vor\" class=\"wp-block-heading\">Was your application rejected? Here's what to do.<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Check the rejection letter:<\/strong> If the insurer bases the rejection on a lack of prospects for success due to a positive benefit-risk ratio, this justification is contestable according to the BGH ruling.<\/li>\n\n\n\n<li><strong>Use of tie-breaking decisions or expert review procedures:<\/strong> According to Section 128 of the German Insurance Contract Act (VVG), the insurance contract must include a procedure by which you can have a rejection due to lack of prospects of success reviewed. Many policies include a binding decision by your lawyer for this purpose.<\/li>\n\n\n\n<li><strong>Submit a new coverage request:<\/strong> If coverage was rejected, a renewed request citing the current case law of the Federal Court of Justice (BGH) may be advisable.<\/li>\n\n\n\n<li><strong>File a cover action:<\/strong> If the insurer maintains its refusal, coverage can be enforced through legal action.<\/li>\n\n\n\n<li><strong>Keep an eye on deadlines:<\/strong> Claims against the vaccine manufacturer expire three years from the end of the year in which you became aware of the damage and the liable party.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-rogert-amp-ulbrich-ihre-anwalte-bei-impfschaden\" class=\"wp-block-heading\">Rogert &amp; Ulbrich: Your lawyers for vaccine injuries<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Rogert &amp; Ulbrich represents vaccine victims nationwide against vaccine manufacturers and <a href=\"https:\/\/ru.law\/en\/versicherungsrecht\/rechtsanwalt-fuer-rechtsschutzversicherung\/\">Legal expenses insurers<\/a>. The partners <a href=\"https:\/\/ru.law\/en\/rechtsanwalt\/dr-marco-rogert\/\">Dr. Marco Rogert<\/a> and <a href=\"https:\/\/ru.law\/en\/rechtsanwalt\/tobias-ulbrich\/\">Tobias Ulbrich<\/a> They conduct numerous proceedings under the Medicines Act, from the action for information under Section 84a AMG to the appeal, and enforce coverage with legal expenses insurers if they refuse to cover the costs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Has your legal expenses insurance refused to cover the costs of a lawsuit against the vaccine manufacturer? Take <a href=\"https:\/\/ru.law\/en\/kontakt\/\">contact<\/a> and secure your claims.<\/p>\n\n\n\n<h2 id=\"h-faqs-zum-bgh-urteil-iv-zr-214-25\" class=\"wp-block-heading\">FAQs on the Federal Court of Justice (BGH) ruling IV ZR 214\/25<\/h2>\n\n\n<div class=\"wp-block-uagb-faq uagb-faq__outer-wrap uagb-block-a987b9db uagb-faq-icon-row uagb-faq-layout-accordion uagb-faq-expand-first-true uagb-faq-inactive-other-true uagb-faq__wrap uagb-buttons-layout-wrap uagb-faq-equal-height     uagb-faq__wrap uagb-buttons-layout-wrap\" data-faqtoggle=\"true\" role=\"tablist\"><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-549e3458\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">What did the Federal Court of Justice (BGH) decide on November 11, 2026?<\/span><\/div><div class=\"uagb-faq-content\"><p>In June 2023, a legal expenses insurer was not allowed to refuse coverage for a claim for damages against the manufacturer of Comirnaty on the grounds that the vaccine had a positive benefit-risk ratio and the claim was hopeless.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-957fd3a0\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">When does a lawsuit have a reasonable chance of success?<\/span><\/div><div class=\"uagb-faq-content\"><p>If the policyholder's legal position appears tenable and evidence can be provided, the insurer may not impose excessive requirements.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-6f714108\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">What point in time is crucial?<\/span><\/div><div class=\"uagb-faq-content\"><p>In principle, the relevant point in time is when the insurer decides on the coverage request. It may not retroactively base its rejection on later rulings by lower courts.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-e0a33b06\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Does the ruling only apply to rejections from 2023?<\/span><\/div><div class=\"uagb-faq-content\"><p>The Federal Court of Justice (BGH) has ruled on a rejection from June 2023. Its reasoning, that difficult and unresolved issues must not be decided in the coverage proceedings and that the taking of evidence must not be anticipated, is also relevant for subsequent rejections.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-a83fc9e3\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">What role does the benefit-risk ratio play?<\/span><\/div><div class=\"uagb-faq-content\"><p>The manufacturer is liable under Section 84 Paragraph 1 Sentence 2 No. 1 of the German Medicines Act (AMG) if the vaccine has harmful effects that exceed an acceptable level. Whether this is the case must be clarified by an expert opinion in the legal proceedings against the manufacturer, not in a dispute with the insurer.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-1cb96d67\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">Which courts were previously involved in the case?<\/span><\/div><div class=\"uagb-faq-content\"><p>The Kleve Regional Court (judgment of February 20, 2025, 6 O 117\/24) and the D\u00fcsseldorf Higher Regional Court (judgment of September 9, 2025, 4 U 33\/25) both dismissed the coverage claim.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-f7929ddf\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">What are the next steps in the process?<\/span><\/div><div class=\"uagb-faq-content\"><p>The Higher Regional Court of D\u00fcsseldorf must hold a new hearing and examine whether the plaintiff's arguments regarding a negative benefit-risk ratio and the other requirements for the claim are sufficient.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-64e3ebc5\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">What can I do if my insurer has refused coverage?<\/span><\/div><div class=\"uagb-faq-content\"><p>Have the rejection reviewed. Options include a binding decision or expert assessment according to your insurance terms, a renewed coverage request, or a legal action to enforce coverage.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-c2bf5abd\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">How does this ruling relate to BGH VI ZR 335\/24?<\/span><\/div><div class=\"uagb-faq-content\"><p>The Sixth Civil Senate ruled on March 9, 2026, that claims for vaccine injury may not be dismissed without taking evidence if the allegations are sufficiently specific. The Fourth Civil Senate is now extending this principle to legal expenses insurance.<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-24b9dd2e\" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewbox= \"0 0 448 512\"><path d=\"M400 288h-352c-17.69 0-32-14.32-32-32.01s14.31-31.99 32-31.99h352c17.69 0 32 14.3 32 31.99S417.7 288 400 288z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\">What documents do I need for an initial assessment?<\/span><\/div><div class=\"uagb-faq-content\"><p>Your insurance policy with terms and conditions, the insurer's letter of rejection, your vaccination record, as well as medical letters and findings regarding your complaints after the vaccination.<\/p><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Federal Court of Justice ruling of November 11, 2026: Legal expenses insurer was not allowed to refuse coverage for a lawsuit against BioNTech due to lack of prospects of success.<\/p>","protected":false},"author":21,"featured_media":990657,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1455],"tags":[1903,14,1465,1888,1904,1457,1902,1885],"class_list":["post-990659","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-impfschaeden","tag-84-amg","tag-bgh","tag-biontech","tag-comirnaty","tag-deckungsklage","tag-impfschaden","tag-iv-zr-214-25","tag-rechtsschutzversicherung"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.8 (Yoast SEO v28.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BGH IV ZR 214\/25: Rechtsschutz muss Impfschadenklage decken<\/title>\n<meta name=\"description\" content=\"BGH vom 11.11.2026: Rechtsschutzversicherer durfte die Deckung f\u00fcr eine Klage gegen BioNTech nicht ablehnen. Was das Urteil f\u00fcr Sie bedeutet.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ru.law\/en\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BGH IV ZR 214\/25: Rechtsschutz darf Impfschadenklage nicht ablehnen\" \/>\n<meta property=\"og:description\" content=\"BGH vom 11.11.2026: Rechtsschutzversicherer durfte die Deckung f\u00fcr eine Klage gegen BioNTech nicht ablehnen. Was das Urteil f\u00fcr Sie bedeutet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ru.law\/en\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/\" \/>\n<meta property=\"og:site_name\" content=\"R&amp;U\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RogertUlbrich\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-12T05:30:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-12T05:30:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marco Rogert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RogertUlbrich\" \/>\n<meta name=\"twitter:site\" content=\"@RogertUlbrich\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/\"},\"author\":{\"name\":\"Marco Rogert\",\"@id\":\"https:\\\/\\\/ru.law\\\/#\\\/schema\\\/person\\\/b020d506e6bbc471b4565d3a98173b87\"},\"headline\":\"BGH IV ZR 214\\\/25: Rechtsschutz darf Impfschadenklage nicht ablehnen\",\"datePublished\":\"2026-11-12T05:30:57+00:00\",\"dateModified\":\"2026-11-12T05:30:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/\"},\"wordCount\":860,\"publisher\":{\"@id\":\"https:\\\/\\\/ru.law\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/AdobeStock_618182265-scaled.jpeg\",\"keywords\":[\"\u00a7 84 AMG\",\"BGH\",\"BioNTech\",\"Comirnaty\",\"Deckungsklage\",\"Impfschaden\",\"IV ZR 214\\\/25\",\"Rechtsschutzversicherung\"],\"articleSection\":[\"Impfsch\u00e4den\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/\",\"url\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/\",\"name\":\"BGH IV ZR 214\\\/25: Rechtsschutz muss Impfschadenklage decken\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ru.law\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/AdobeStock_618182265-scaled.jpeg\",\"datePublished\":\"2026-11-12T05:30:57+00:00\",\"dateModified\":\"2026-11-12T05:30:58+00:00\",\"description\":\"BGH vom 11.11.2026: Rechtsschutzversicherer durfte die Deckung f\u00fcr eine Klage gegen BioNTech nicht ablehnen. Was das Urteil f\u00fcr Sie bedeutet.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/AdobeStock_618182265-scaled.jpeg\",\"contentUrl\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/AdobeStock_618182265-scaled.jpeg\",\"width\":2560,\"height\":1707,\"caption\":\"Impfstoff\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ru.law\\\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/ru.law\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BGH IV ZR 214\\\/25: Rechtsschutz darf Impfschadenklage nicht ablehnen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ru.law\\\/#website\",\"url\":\"https:\\\/\\\/ru.law\\\/\",\"name\":\"R&U\",\"description\":\"Verbraucheranw\u00e4lte\",\"publisher\":{\"@id\":\"https:\\\/\\\/ru.law\\\/#organization\"},\"alternateName\":\"Rogert & Ulbrich\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ru.law\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ru.law\\\/#organization\",\"name\":\"Kanzlei Rogert & Ulbrich\",\"url\":\"https:\\\/\\\/ru.law\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ru.law\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/logo-ru-law.svg\",\"contentUrl\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/logo-ru-law.svg\",\"width\":992,\"height\":259,\"caption\":\"Kanzlei Rogert & Ulbrich\"},\"image\":{\"@id\":\"https:\\\/\\\/ru.law\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RogertUlbrich\\\/\",\"https:\\\/\\\/x.com\\\/RogertUlbrich\",\"https:\\\/\\\/www.instagram.com\\\/rogertulbrich\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rogert-ulbrich\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCganCgpvwpPFqMFf1vVmG2A\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ru.law\\\/#\\\/schema\\\/person\\\/b020d506e6bbc471b4565d3a98173b87\",\"name\":\"Marco Rogert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/ru-law-rogert.png\",\"url\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/ru-law-rogert.png\",\"contentUrl\":\"https:\\\/\\\/ru.law\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/ru-law-rogert.png\",\"caption\":\"Marco Rogert\"},\"description\":\"Dr. Marco Rogert ist Rechtsanwalt und zweifacher Fachanwalt mit Sitz in D\u00fcsseldorf. Er ber\u00e4t und vertritt Mandanten bundesweit im Bank- und Kapitalanlagerecht, bei Kryptobetrug und KI-rechtlichen Fragen sowie im Transport- und Speditionsrecht. Bekannt wurde er als einer der f\u00fchrenden Anw\u00e4lte in der Aufarbeitung des Abgasskandals und als Mitbegr\u00fcnder der ersten Musterfeststellungsklage gegen die Volkswagen AG.\",\"sameAs\":[\"https:\\\/\\\/ru.law\\\/rechtsanwalt\\\/dr-marco-rogert\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/marco-prof-dr-rogert-248037407\\\/\"],\"honorificPrefix\":\"Dr\",\"knowsAbout\":[\"Bank- und Kapitalmarktrecht\",\"Transport- und Speditionsrecht\",\"KI-Recht\",\"Kryptobetrug\",\"Abgasskandal\"],\"url\":\"https:\\\/\\\/ru.law\\\/rechtsanwalt\\\/dr-marco-rogert\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BGH IV ZR 214\/25: Rechtsschutz muss Impfschadenklage decken","description":"BGH vom 11.11.2026: Rechtsschutzversicherer durfte die Deckung f\u00fcr eine Klage gegen BioNTech nicht ablehnen. Was das Urteil f\u00fcr Sie bedeutet.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ru.law\/en\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/","og_locale":"en_GB","og_type":"article","og_title":"BGH IV ZR 214\/25: Rechtsschutz darf Impfschadenklage nicht ablehnen","og_description":"BGH vom 11.11.2026: Rechtsschutzversicherer durfte die Deckung f\u00fcr eine Klage gegen BioNTech nicht ablehnen. Was das Urteil f\u00fcr Sie bedeutet.","og_url":"https:\/\/ru.law\/en\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/","og_site_name":"R&amp;U","article_publisher":"https:\/\/www.facebook.com\/RogertUlbrich\/","article_published_time":"2026-11-12T05:30:57+00:00","article_modified_time":"2026-11-12T05:30:58+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg","type":"image\/jpeg"}],"author":"Marco Rogert","twitter_card":"summary_large_image","twitter_creator":"@RogertUlbrich","twitter_site":"@RogertUlbrich","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/#article","isPartOf":{"@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/"},"author":{"name":"Marco Rogert","@id":"https:\/\/ru.law\/#\/schema\/person\/b020d506e6bbc471b4565d3a98173b87"},"headline":"BGH IV ZR 214\/25: Rechtsschutz darf Impfschadenklage nicht ablehnen","datePublished":"2026-11-12T05:30:57+00:00","dateModified":"2026-11-12T05:30:58+00:00","mainEntityOfPage":{"@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/"},"wordCount":860,"publisher":{"@id":"https:\/\/ru.law\/#organization"},"image":{"@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/#primaryimage"},"thumbnailUrl":"https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg","keywords":["\u00a7 84 AMG","BGH","BioNTech","Comirnaty","Deckungsklage","Impfschaden","IV ZR 214\/25","Rechtsschutzversicherung"],"articleSection":["Impfsch\u00e4den"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/","url":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/","name":"BGH IV ZR 214\/25: Rechtsschutz muss Impfschadenklage decken","isPartOf":{"@id":"https:\/\/ru.law\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/#primaryimage"},"image":{"@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/#primaryimage"},"thumbnailUrl":"https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg","datePublished":"2026-11-12T05:30:57+00:00","dateModified":"2026-11-12T05:30:58+00:00","description":"BGH vom 11.11.2026: Rechtsschutzversicherer durfte die Deckung f\u00fcr eine Klage gegen BioNTech nicht ablehnen. Was das Urteil f\u00fcr Sie bedeutet.","breadcrumb":{"@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/#primaryimage","url":"https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg","contentUrl":"https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg","width":2560,"height":1707,"caption":"Impfstoff"},{"@type":"BreadcrumbList","@id":"https:\/\/ru.law\/bgh-iv-zr-214-25-rechtsschutz-impfschaden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/ru.law\/"},{"@type":"ListItem","position":2,"name":"BGH IV ZR 214\/25: Rechtsschutz darf Impfschadenklage nicht ablehnen"}]},{"@type":"WebSite","@id":"https:\/\/ru.law\/#website","url":"https:\/\/ru.law\/","name":"R&amp;U","description":"Consumer lawyers","publisher":{"@id":"https:\/\/ru.law\/#organization"},"alternateName":"Rogert & Ulbrich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ru.law\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ru.law\/#organization","name":"Rogert &amp; Ulbrich Law Firm","url":"https:\/\/ru.law\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ru.law\/#\/schema\/logo\/image\/","url":"https:\/\/ru.law\/wp-content\/uploads\/2020\/12\/logo-ru-law.svg","contentUrl":"https:\/\/ru.law\/wp-content\/uploads\/2020\/12\/logo-ru-law.svg","width":992,"height":259,"caption":"Kanzlei Rogert & Ulbrich"},"image":{"@id":"https:\/\/ru.law\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RogertUlbrich\/","https:\/\/x.com\/RogertUlbrich","https:\/\/www.instagram.com\/rogertulbrich\/","https:\/\/www.linkedin.com\/company\/rogert-ulbrich\/","https:\/\/www.youtube.com\/channel\/UCganCgpvwpPFqMFf1vVmG2A"]},{"@type":"Person","@id":"https:\/\/ru.law\/#\/schema\/person\/b020d506e6bbc471b4565d3a98173b87","name":"Marco Rogert","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ru.law\/wp-content\/uploads\/2025\/09\/ru-law-rogert.png","url":"https:\/\/ru.law\/wp-content\/uploads\/2025\/09\/ru-law-rogert.png","contentUrl":"https:\/\/ru.law\/wp-content\/uploads\/2025\/09\/ru-law-rogert.png","caption":"Marco Rogert"},"description":"Dr. Marco Rogert is a lawyer and certified specialist in two areas of law, based in D\u00fcsseldorf. He advises and represents clients nationwide in banking and investment law, cryptocurrency fraud and AI-related legal issues, as well as in transport and freight forwarding law. He became known as one of the leading lawyers in the handling of the emissions scandal and as a co-founder of the first model declaratory action against Volkswagen AG.","sameAs":["https:\/\/ru.law\/rechtsanwalt\/dr-marco-rogert\/","https:\/\/www.linkedin.com\/in\/marco-prof-dr-rogert-248037407\/"],"honorificPrefix":"Dr","knowsAbout":["Bank- und Kapitalmarktrecht","Transport- und Speditionsrecht","KI-Recht","Kryptobetrug","Abgasskandal"],"url":"https:\/\/ru.law\/rechtsanwalt\/dr-marco-rogert\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg",2560,1707,false],"thumbnail":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg",128,85,false],"medium":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg",2560,1707,false],"medium_large":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-768x512.jpeg",768,512,true],"large":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-scaled.jpeg",2560,1707,false],"1536x1536":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-1536x1024.jpeg",1536,1024,true],"2048x2048":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-2048x1365.jpeg",2048,1365,true],"trp-custom-language-flag":["https:\/\/ru.law\/wp-content\/uploads\/2026\/11\/AdobeStock_618182265-18x12.jpeg",18,12,true]},"uagb_author_info":{"display_name":"Marco Rogert","author_link":"https:\/\/ru.law\/rechtsanwalt\/dr-marco-rogert\/"},"uagb_comment_info":0,"uagb_excerpt":"BGH-Urteil vom 11.11.2026: Rechtsschutzversicherer durfte die Deckung f\u00fcr eine Klage gegen BioNTech nicht wegen fehlender Erfolgsaussicht verweigern.","_links":{"self":[{"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/posts\/990659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/comments?post=990659"}],"version-history":[{"count":1,"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/posts\/990659\/revisions"}],"predecessor-version":[{"id":990660,"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/posts\/990659\/revisions\/990660"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/media\/990657"}],"wp:attachment":[{"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/media?parent=990659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/categories?post=990659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ru.law\/en\/wp-json\/wp\/v2\/tags?post=990659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}